Skip to content
DeLong Plastic Surgery

Research & innovation

Research & Innovation

As an Assistant Professor-in-Residence at UCLA, NIH-funded investigator, and FDA advisor, Dr. DeLong studies questions that shape reconstructive outcomes, breast-implant safety, and medical-device regulation.

Academic medicine

Research grounded in patient needs.

Dr. DeLong is an active NIH-funded researcher whose work focuses on cancer and breast reconstruction outcomes, breast-implant safety, and medical-device regulatory science. He completed a fellowship at the FDA Center for Devices and Radiological Health and has served as a voting member of the FDA General and Plastic Surgery Devices Panel.

He also built a 95-site quality improvement program for breast reconstruction, bringing shared measurement and learning to reconstructive care across participating sites.

His academic service includes manuscript review for multiple journals.

NIH-funded research

Investigation of reconstructive outcomes and clinically meaningful questions.

FDA experience

Training in device regulation and service on a federal advisory panel.

Implant safety

Research on breast implants, reconstruction materials, and device science.

Quality improvement

Built a 95-site quality improvement program for breast reconstruction.

Scholarly recognition

Best Breast Paper (2020) and Bernard G. Sarnat Award (2019).